Talking Techniques

Share

How PCR has prevailed during the COVID-19 pandemic

Season 2, Ep. 5

In Part 3 of our COVID-19 diagnostics and detection miniseries, supported by Roche, we explore the contribution PCR has made towards diagnosis during the pandemic. Providing me with an insight into the world of PCR diagnostics is Tyler Miller, Clinical Pathology Resident and Research Fellow at Massachusetts General Hospital (MA, USA), where he was instrumental in setting up the testing regimen for the Hospital.

Ty details the attributes of PCR that lead to it becoming the gold standard for diagnostic tests, before explaining the variance in clinical detection rate during a patient’s disease course and how this variation correlates with the infectivity of the patient. Ty also delves into the variety of sample collection methods available, how each of these methods compares in terms of sensitivity and their ability to be integrated into exciting novel PCR techniques.

We also look at the work of the Broad Institute in establishing a mass testing effort that involved automation, workflow optimization and hundreds of new staff, ultimately leading to the delivery of 100,000 tests a day, almost 5% of the USA’s total COVID-19 testing at the time. All of this rapid work has led to dramatic changes in the PCR technique and process. These changes are perhaps exemplified by PCR testing without RNA extraction and purification, which Ty explains was partly developed due to the limited supplies available to researchers at the beginning of the pandemic.


Contents

  • Introduction: 00:00-02:00
  • Why PCR tests are so valuable: 02:00-03:10
  • Changes in clinical detection rate and infectivity: 03:10-8:00
  • Infectivity and exceptions to the rule: 08:00-09:00
  • Sample collection methods, sensitivity and encouraging testing uptake 09:00-17:00
  • The Broad Institute’s mass testing regimen: 17:00-21:00
  • Developments during the pandemic and no RNA extraction PCR: 21:00-27:00
  • Dreams for improving COVID-19 testing: 27:00- 30:00


This episode was supported by Roche sequencing and life science. Follow these links to find out more about the LightCycler 480 System and LightCycler 96 System.


More Episodes

6/18/2021

From space to the streets: infectious disease sampling in extreme conditions and extraordinary circumstances

Season 2, Ep. 10
In this episode, we take a look at one of the key steps of infectious disease research, sample collection; exploring the challenges associated with the step and the solutions available to improve infectious disease research around the globe.Exploring the trials and tribulations of infectious disease sample collection with me is Stanislav Forman, Product Developer at Zymo Research (CA, USA). Stan explains the extreme environments in which sample collection often occurs; revealing the difficult transit and storage requirements –often involving cold chain logistics –that can derail infectious disease studies early on.Find out how key solutions to these problems have been successfully workshopped with the US military and have even been used in work with NASA to conduct safe sample collection in space. And discover just how successful these solutions can be when faced with the blazing wreckage of a transit vehicle…ContentsIntroductions: 00:00-01:20Key challenges of sample collection for infectious disease research: 01:20-02:30Additional challenges presented by COVID-19: 02:30-05:00The emergence of at-home testing: 05:00-07:00Established practices for sample collection and introducing DNA/RNA shield: 07:00-09:00Protecting DNA/RNA samples: 09:00-11:00Working with NASA on sample collection and protection in space: 11:00-14:20Protecting samples in a blazing transit van: 14:20-15:25The impact of inactivating and preserving sample collection products on infectious disease research: 15:30-16:30Areas for improvement in sample collection: 16:30-17:30Closing statements: 17:30-19:20
6/11/2021

Revealing the regulome: using multiomic approaches to explore epigenetics and DNA expression

Season 2, Ep. 9
Explore the realm of epigenetics and gene expression, discovering the different omic ‘lenses’ used to examine these processes and the power of single-cell studies to reveal a comprehensive multiomic view of cells and their biology.This episode features the ever-buoyant Will Greenleaf, Associate Professor of Genetics at Stanford University School of Medicine (CA, USA) and head of the Greenleaf Lab. Will takes us through his lab’s work, detailing his attempts to understand the compacting of DNA into cell nuclei and how this impacts gene expression and epigenetic regulation.Discover the emerging new research focus that Will has coined the “Regulome” – the collection of physical molecular components that control gene expression through factors such as chromatin accessibility. To explore these new frontiers Will often encounters questions with no technologies available to ask them. So what does he do? Invent the technologies he needs! Find out how his lab came to develop the, now widely used, ATAC-Seq and learn of the new tools that he is looking to develop to solve even more perceptive questions.This episode has it all, and also reveals the potential of Will’s single-cell multiomic approaches in cancer research, virology and HIV. Contents:·Introductions: 00:00-02:00·The exploring the physical genome: 02:00-03:15·Chromatin accessibility: 03:15-05:15·Introducing the ‘Regulome’: 05:15-07:15·The importance of multiomics for the study of gene expression: 07:15-07:55·DNA methylation and histone organization: 07:55-10:30·Real-world impact of this research: 10:30-12:30·Will’s varied career path: 12:30-16:15·Combining multiomic datasets with computational biology and physics experience: 16:15-18:40·Single-cell techniques: 18:40-21:50·Developing ATAC-Seq: 21:50-23:50·New tools in development: 23:50-27:30·Insights into the epigenetics of cancer: 27:30-29:35·Insights into virology and HIV latency: 29:35-32:10·One wish to help explore the regulome. 32:10-33:00
5/28/2021

The oncolytic Trojan horse: Immune cells, the tumor microenvironment and the invasion of neurons

Season 2, Ep. 8
This episode, supported by Bethyl, delves into the realm of the tumor microenvironment (TME), exploring the cells that reside there and how they interact to promote tumor growth and metastasis. Discover how immune cells are attracted and manipulated by tumor cells enabling the cancer to invade neurons where they can then travel throughout the body.Providing an expert's insight into this topic is Moran Amit, Assistant Professor at the MD Anderson Cancer Center (TX, USA). Moran exposes the nebulous interactions in the TME and describes the techniques that he uses to interrogate it, in the hope that by further understanding these interactions we will be able to design more successful, targeted therapies for neurotropic cancers.Contents:·Introductions: 00:00-01:20·The key cells of the TME: 01:20-02:50·How cells of the TME support the tumor: 02:50-05:45·How cancer cells influence and impact immune cells: 05:45-07:25·The invasion of cancers into the neurons: 07:27-9:45·Recruitment of neurons to the TME: 09:45-10:55·The evolution of neuron recruitment to the TME: 10:55-15:00·Techniques involved in the study of the TME: 15:00-17:00·Tips for best practice: 17:00-18:00·Tumors with neural networks: 18:00-20:05·Clinical impact of research: 20:05-21:50·The cancers impacted the most by this research: 21:50-23:25·The impact of neural invasion on patients and neurons: 23:25-25:30·One thing to improve our understanding of the TME: 25:30-28:00